[Ganciclovir 0.15% ophthalmic gel in the treatment of adenovirus keratoconjunctivitis].

Purpose: To evaluate the efficacy and the toxicity of 0.15% ganciclovir gel in the treatment of adenoviral conjunctivitis and in preventing ocular complications after adenoviral conjunctivitis, such as corneal infiltrates and pseudomembranes.

Methods: Double blind, interventional and randomized clinical trial.

[Ocular wavefront aberrations in patients with facial dystonia treated with botulinum toxin].

Purpose: To analyze the ocular wavefront aberrations in patients with facial dystonia treated with botulinum toxin A.

Methods: Patients with benign essential blepharospasm and hemifacial spasm in activity underwent slit lamp examination and bilateral wavefront analysis under pharmacologic mydriasis using Alcon LADARvision wavefront aberrometry system. After that, all patients were treated with botulinum toxin A injections performed by the same ophthalmologist.